German American Bancorp Inc. Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

German American Bancorp Inc. lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,115 shares of the healthcare conglomerate’s stock after buying an additional 2,060 shares during the period. UnitedHealth Group makes up approximately 2.1% of German American Bancorp Inc.’s holdings, making the stock its 13th largest holding. German American Bancorp Inc.’s holdings in UnitedHealth Group were worth $19,946,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. China Universal Asset Management Co. Ltd. boosted its position in shares of UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after purchasing an additional 1,857 shares in the last quarter. Quent Capital LLC boosted its stake in UnitedHealth Group by 5.5% in the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares in the last quarter. EntryPoint Capital LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $75,000. Rodgers Brothers Inc. raised its holdings in UnitedHealth Group by 2.4% in the 1st quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock worth $417,000 after acquiring an additional 20 shares during the last quarter. Finally, Guardian Capital LP raised its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Guardian Capital LP now owns 56,015 shares of the healthcare conglomerate’s stock worth $27,711,000 after purchasing an additional 477 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 4.1 %

UNH opened at $600.50 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average of $582.52 and a 200 day moving average of $551.60. The firm has a market cap of $552.63 billion, a P/E ratio of 39.12, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles